2025 annual financial data
iBio 2025 Operating margin
Direct answer
Operating margin was -4,650.5%.
Operating income was -18,602,000 USD and net income was -18,377,000 USD.
Operating cash flow was -15,304,000 USD.
Get free iBio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 400,000 USD
- Operating income
- -18,602,000 USD
- Net income
- -18,377,000 USD
- Operating cash flow
- -15,304,000 USD